Molina Healthcare, Inc. (NYSE:MOH) Given Consensus Recommendation of “Moderate Buy” by Analysts

Shares of Molina Healthcare, Inc. (NYSE:MOH) have been given an average rating of “Moderate Buy” by the twelve brokerages that are presently covering the firm, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, four have assigned a hold recommendation, six have given a buy recommendation and one has given a strong buy recommendation to the company. The average 12-month price objective among analysts that have issued a report on the stock in the last year is $407.45.

MOH has been the subject of a number of recent analyst reports. Barclays dropped their price target on Molina Healthcare from $437.00 to $430.00 and set an “equal weight” rating for the company in a report on Thursday, April 25th. Bank of America cut Molina Healthcare from a “neutral” rating to an “underperform” rating and set a $439.00 target price for the company. in a research note on Thursday, March 28th. Baird R W raised Molina Healthcare to a “strong-buy” rating in a research note on Thursday, May 30th. TD Cowen decreased their price objective on Molina Healthcare from $453.00 to $412.00 and set a “buy” rating for the company in a research note on Tuesday, April 30th. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and set a $406.00 price objective on shares of Molina Healthcare in a research note on Thursday, April 4th.

Insider Activity

In other news, COO James Woys sold 10,000 shares of the business’s stock in a transaction dated Wednesday, May 22nd. The stock was sold at an average price of $345.15, for a total value of $3,451,500.00. Following the sale, the chief operating officer now directly owns 53,613 shares in the company, valued at $18,504,526.95. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. In related news, COO James Woys sold 10,000 shares of the company’s stock in a transaction dated Wednesday, May 22nd. The stock was sold at an average price of $345.15, for a total transaction of $3,451,500.00. Following the sale, the chief operating officer now owns 53,613 shares in the company, valued at $18,504,526.95. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Ronna Romney sold 250 shares of the company’s stock in a transaction dated Tuesday, May 21st. The stock was sold at an average price of $343.27, for a total value of $85,817.50. Following the sale, the director now owns 16,945 shares in the company, valued at approximately $5,816,710.15. The disclosure for this sale can be found here. Corporate insiders own 1.11% of the company’s stock.

Hedge Funds Weigh In On Molina Healthcare

A number of institutional investors have recently bought and sold shares of the business. Boston Partners increased its position in Molina Healthcare by 14.8% during the first quarter. Boston Partners now owns 798,950 shares of the company’s stock worth $328,101,000 after buying an additional 103,245 shares during the last quarter. Cetera Advisors LLC acquired a new position in Molina Healthcare during the first quarter worth approximately $339,000. Cetera Investment Advisers increased its position in Molina Healthcare by 516.4% during the first quarter. Cetera Investment Advisers now owns 10,238 shares of the company’s stock worth $4,206,000 after buying an additional 8,577 shares during the last quarter. Swedbank AB acquired a new position in Molina Healthcare during the first quarter worth approximately $69,320,000. Finally, Comerica Bank increased its position in Molina Healthcare by 2.5% during the first quarter. Comerica Bank now owns 14,037 shares of the company’s stock worth $5,767,000 after buying an additional 341 shares during the last quarter. Institutional investors and hedge funds own 98.50% of the company’s stock.

Molina Healthcare Price Performance

Shares of MOH stock opened at $296.10 on Thursday. The stock has a 50 day moving average of $323.97 and a two-hundred day moving average of $361.41. The company has a current ratio of 1.49, a quick ratio of 1.49 and a debt-to-equity ratio of 0.53. Molina Healthcare has a 12 month low of $288.79 and a 12 month high of $423.92. The company has a market capitalization of $17.35 billion, a P/E ratio of 16.07, a P/E/G ratio of 0.91 and a beta of 0.58.

Molina Healthcare (NYSE:MOH) last posted its earnings results on Wednesday, April 24th. The company reported $5.73 EPS for the quarter, topping the consensus estimate of $5.46 by $0.27. Molina Healthcare had a return on equity of 29.86% and a net margin of 2.99%. The business had revenue of $9.93 billion during the quarter, compared to the consensus estimate of $9.45 billion. During the same quarter last year, the company earned $5.81 EPS. Molina Healthcare’s revenue was up 21.9% on a year-over-year basis. As a group, equities analysts expect that Molina Healthcare will post 23.56 EPS for the current year.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.